BGI Genomics Co Ltd.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From BGI Genomics Co Ltd.
Jury Awards Nearly $334M To MGI Tech In Illumina Patent Suit
The jury said the infringement, which involved patents on two-channel sequencing chemistry technology, had been “willful” and turned down Illumina’s counterclaims.
Illumina Wins Injunction Keeping BGI Sequencers Off US Market
BGI, and its subsidiary MGI, can’t sell the infringing products in the US until after Illumina’s patents expire.
China Detains Legend Biotech CEO, Exposes Genetic Material Minefield
Frank Zhang, co-founder and chair of the Hong Kong-listed Chinese biotech Genscript, parent of Nasdaq-listed cell therapy star, Legend Biotech, has been detained by Chinese authorities, along with four employees.
Regulatory, Security Concerns Force Wuxi NextCODE To Cut China Ties
As China tightens its grip over clinical research using human genetic data in the country, and the US increases scrutiny over the use of personal data, multinational drug developers may face a difficult choice or even create separate entities to cater to local regulatory requirements. WuXi NextCODE provides one interesting case study.
- Drug Discovery Tools
Drug Discovery Tools
- Other Names / Subsidiaries
- BGI Europe A/S
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.